SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001437749-24-002819
Filing Date
2024-02-01
Accepted
2024-02-01 16:00:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A rbar20240130_sc13ga.htm SC 13G/A 50090
  Complete submission text file 0001437749-24-002819.txt   51456
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Subject) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-59335 | Film No.: 24586825
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address
Business Address
BARBIER REMI (Filed by) CIK: 0001133806 (see all company filings)

Type: SC 13G/A